C07D 333/14
Radicals substituted by singly bound hetero atoms other than halogen
C07D333/14 (Radicals substituted by singly bound hetero atoms other than halogen) appears on 2,117 US grants and 1,728 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,117
- Published applications
- 1,728
- Assignees
- 1,003
- Inventors
- 6,315
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 22 | 0 |
| 1977 | 31 | 0 |
| 1978 | 34 | 0 |
| 1979 | 20 | 0 |
| 1980 | 29 | 0 |
| 1981 | 33 | 0 |
| 1982 | 32 | 0 |
| 1983 | 19 | 0 |
| 1984 | 30 | 0 |
| 1985 | 23 | 0 |
| 1986 | 14 | 0 |
| 1987 | 28 | 0 |
| 1988 | 33 | 0 |
| 1989 | 34 | 0 |
| 1990 | 36 | 0 |
| 1991 | 34 | 0 |
| 1992 | 27 | 0 |
| 1993 | 38 | 0 |
| 1994 | 33 | 0 |
| 1995 | 31 | 0 |
| 1996 | 52 | 0 |
| 1997 | 52 | 0 |
| 1998 | 33 | 0 |
| 1999 | 24 | 0 |
| 2000 | 40 | 0 |
| 2001 | 56 | 7 |
| 2002 | 84 | 73 |
| 2003 | 74 | 115 |
| 2004 | 61 | 115 |
| 2005 | 47 | 108 |
| 2006 | 64 | 114 |
| 2007 | 74 | 107 |
| 2008 | 65 | 112 |
| 2009 | 71 | 112 |
| 2010 | 83 | 97 |
| 2011 | 78 | 78 |
| 2012 | 69 | 70 |
| 2013 | 72 | 72 |
| 2014 | 64 | 65 |
| 2015 | 55 | 57 |
| 2016 | 50 | 58 |
| 2017 | 45 | 60 |
| 2018 | 40 | 38 |
| 2019 | 35 | 39 |
| 2020 | 37 | 41 |
| 2021 | 21 | 43 |
| 2022 | 27 | 38 |
| 2023 | 20 | 29 |
| 2024 | 22 | 33 |
| 2025 | 15 | 29 |
| 2026 | 6 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Compounds for the treatment of bacterial infections and potentiation of antibiotics8 Sep 2026US 12,728,105 B2Georgia State University Research Foundation, Inc.
- Vesicular monoamine transporter-2 ligands and their use in the treatment of psychostimulant abuse26 May 2026US 12,637,410 B2University of Kentucky Research Foundation
- Sulfur and amide tropolone inhibitors of nucleotidyl transferases and uses therefor21 Apr 2026US 12,606,529 B2Research Foundation of the City University of New York
- 3-aryloxy-3-five-membered heteroaryl propylamine compound, and crystal form and use thereof10 Mar 2026US 12,570,643 B2Shanghai Leado Pharmatech Co. Ltd.
- Heterocyclyl pyrimidines and triazines as novel fungicides3 Mar 2026US 12,565,489 B2Bayer Aktiengesellschaft
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Pyridine-piperazine-based scaffolds as highly potent and selective neurolysin activators1 Oct 2026US 2026/0294897 A1Board of Regents of the University of Nebraska
- Hdac1/2 selective inhibitor and use thereof1 Oct 2026US 2026/0297110 A1Wigen Biomedicine Technology (Shanghai) Co., Ltd.
- Rotigotine prodrug derivatives, pharmaceutical compositions thereof and uses thereof10 Sep 2026US 2026/0263416 A1Yantai Institute of Pharmaceutical Science
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
Most cited
By later US patents
- Phenyl heterocycles as cox-2 inhibitors281US 5,474,995 AMerck Frosst Canada, Inc. · 1995
- Phenyl heterocycles as cox-2 inhibitors208US 5,550,142 AMerck Frosst Canada, Inc. · 1996
- Phenyl heterocycles as COX-2 inhibitors204US 5,536,752 AMerck Frosst Canada, Inc. · 1996
- Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2192US 5,521,213 AMerck Frosst Canada, Inc. · 1996
- Heterocyclic containing biphenyl aP2 inhibitors and method135US 6,548,529 B1Bristol-Myers Squibb Company · 2003